Literature DB >> 11498375

b-Lactamase inhibitors.

Malcolm G. P. Page1.   

Abstract

The use of beta-lactamase inhibitors in combination with a beta-lactamase-susceptible antibiotic is a useful strategy to rescue otherwise good antibiotics from failure. However, recent years have seen a rise in the numbers of beta-lactamases that are insensitive to the available beta-lactamase inhibitors. This review summarizes of the mechanisms of action of the principal types of inhibitors and the ways in which beta-lactamase are thought to develop resistance towards them. Ten general classes of inhibitors are reviewed, especially those of therapeutic importance (clavulanic acid, penam sulfones and carbapenems). Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Year:  2000        PMID: 11498375     DOI: 10.1054/drup.2000.0137

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  19 in total

1.  Inhibition of class D beta-lactamases by acyl phosphates and phosphonates.

Authors:  S A Adediran; Michiyoshi Nukaga; Stéphane Baurin; J-M Frère; R F Pratt
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 2.  Class D β-lactamases: a reappraisal after five decades.

Authors:  David A Leonard; Robert A Bonomo; Rachel A Powers
Journal:  Acc Chem Res       Date:  2013-07-31       Impact factor: 22.384

3.  Role of Asp104 in the SHV beta-lactamase.

Authors:  Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Jodi M Thomson; Mark W Ruszczycky; Vernon E Anderson; Marianne Pusztai-Carey; Magdalena Taracila; Marion S Helfand; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

5.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

6.  Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by antisense oligodeoxynucleotides.

Authors:  Renee Sarno; Hongphuc Ha; Natalia Weinsetel; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  Comparison of beta-lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase.

Authors:  Tao Sun; Michiyoshi Nukaga; Kayoko Mayama; Emory H Braswell; James R Knox
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

8.  Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.

Authors:  Matthew Kalp; Paul R Carey
Journal:  Biochemistry       Date:  2008-10-16       Impact factor: 3.162

Review 9.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.

Authors:  Geoffrey W Stone; Qin Zhang; Rosario Castillo; V Ramana Doppalapudi; Analia R Bueno; Jean Y Lee; Qing Li; Maria Sergeeva; Gody Khambatta; Nafsika H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.